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Introduction
Primary immunodeficiency (PID) resulting from disorders of neutrophil function predispose to bacterial and fungal infections. Defined mechanisms include defects of respiratory burst, integrin activation and neutrophil granules 1 MKL1 and MKL2 are members of the myocardin-related transcription factor (MRTF) protein family 3, 4 . MRTFs are held in an inactive state in the cytoplasm in a reversible complex with
G-actin. Stimulation of Rho GTPases promotes incorporation of G-actin into F-actin filaments, releasing MRTFs from G-actin and allowing their import to the nucleus, where
MRTFs function as coactivators of serum response factor (SRF) and stimulate SRFmediated transcription of actin and actin cytoskeleton-related genes 5, 6 . In contrast with myocardin, which is restricted to cardiomyocytes and smooth muscles cells, MKL1 and MKL2 are widely expressed 3 . While MKL2-and myocardin-knockout mice are embryonically lethal, MKL1-knockout mice have a less severe phenotype, demonstrating premature involution of mammary glands, partial embryonic lethality due to abnormal cardiogenesis associated with myocardial cell death and reduced platelet counts in peripheral blood 7, 8 .
Several studies indicate that MKL1 is required for maturation and migration of megakaryocytes [8] [9] [10] and its absence can only partially be compensated for by the presence of MKL2. However, the role of MKL1 in myeloid or lymphoid lineage immune cells has not been reported. Here we describe for the first time human MKL1-deficiency caused by a homozygous mutation in a child with severe bacterial infections. Loss of MKL1 resulted in low levels of F-actin and impaired cytoskeletal functions of neutrophils and myeloid lineage dendritic cells, as well as lymphoid lineage cells. These findings define MKL1-deficiency as a novel PID and elucidate a non-redundant role for MKL1 in human immune cells.
Material and Methods

Human neutrophil isolation and peripheral blood dendritic cell cultures
For personal use only. on May 1, 2017 . by guest www.bloodjournal.org From Blood samples were obtained with informed consent from the parents of the patient in accordance with the Declaration of Helsinki and with approval from local ethics committees (04/Q0501/119 and 06/Q0508/16). Neutrophils were isolated from healthy donor or patient blood. Briefly, 2mL of a 5% dextran-saline solution was added to 10 mL of blood and gently mixed by inversion before let to sediment for 30 minutes. The plasma layer was collected and overlaid on an equal volume of Ficoll-Paque and the centrifuged at 1800 rpm for 10 minutes. The PBMC layer was taken for CD14-positive cells selection while the neutrophil pellet was resuspended in distilled water for 20 seconds before addition of 2x saline solution to restore isotonocity. The neutrophils were then centrifuged at 1200 rpm for 7 minutes and resuspended in warm complete RPMI.
CD14-positive cells were magnetically labelled and positively selected on LS columns (Miltenyi Biotec). The column flow-through, representing the unlabeled lymphocyte fraction, was collected for further experiments. CD14 positive cells were eluted from the column and seeded on day 0 at 1 x10 6 cells/well in 6-well plates in complete growth media (RPMI +10% FCS + Pen/Strep) supplemented with 100ng/ml rhGMCSF (granulocyte-macrophage colony stimulating factor) and 25ng/mL rhIl-4 (recombinant human interleukin-4). Fresh cytokines were added on day 3 and cells were harvested for use on day 6 or 7.
THP1 and HL-60 cell culture
THP1 cells were cultured in suspension in RPMI-Glutamax supplemented with 10% FCS and Pen/Strep. Cells were maintained at 0.5-1x10 6 cells/mL. For dendritic cells differentiation, THP1 cells were cultured in the presence of 10ng/mL rhIL-4 and 10ng/mL rhGM-CSF for 6 days. Cells were split on days 2 and 5 with addition of fresh cytokines. Both adherent and suspension cells were harvested for use on day 6 or 7.
HL-60 cells were maintained in culture at a concentration between 0.1 and 1.5x10 6 cells/mL in RPMI supplemented with 10% FCS and 25mM HEPES. To differentiate the HL-60 into neutrophil-like cells (dHL-60), 1x10 6 cells were cultured for 5 days in media supplemented with 1.3% of DMSO in a T25 flask.
Migration experiments:
Depending on the cells used for the experiment, coverslips were coated with a solution of We report a girl born to second cousin consanguineous parents (Figure 1a ) who presented in the first year of life with Pseudomonas septic shock associated with meningitis, malignant otitis externa, and more than thirty cutaneous and subcutaneous abscesses. This followed a primary chicken pox infection that was considered to have a normal course with many lesions that had crusted over by two weeks and which did not require hospitalisation. Around two weeks after the onset of chickenpox, she presented with another pustule in her ear that was initially thought to be a recurrence of VZV. However, she developed skin lesions and became acutely unwell with pseudomonas septicaemia. She was very slow to respond to appropriate antibiotic therapy, and received a month of intravenous antibiotics before being discharged home on oral ciprofloxacin. She recovered and was commenced on antibiotic prophylaxis and empiric immunoglobulin replacement therapy. Despite this, she continued to have intermittent deep skin infections, characterised by purple painful lesions, usually in the peripheries, that responded to oral antibiotics. In her past history, she had received seven days of intravenous antibiotics for possible sepsis at day 2 of age, had a history of pseudomonas ear infections and failed to thrive. BCG vaccination, given in the neonatal period, resulted in a large ulcerated abscess, requiring several months of oral antimycobacterial treatment.
Her initial investigations revealed intermittent mild thrombocytopenia (platelets typically ranging from 50-150 x10 9 /L). Complement function, MBL levels, CD11a and CD18 expression, neutrophil oxidative burst activity, lymphocyte subsets, naive and memory T-cell numbers, and T-cell proliferation to PHA were normal. Her immunoglobulins levels were also unremarkable; vaccine responses were not measured (Table S1 ). Only her T-cell proliferation to anti-CD3 antibody was defective, suggesting a specific defect downstream of the T-cell receptor. In view of a clinical suspicion of neutrophil dysfunction, neutrophil phagocytosis was tested using pre-opsonised E.Coli and found to be abnormal on two occasions (Figure 1 b, c). As this suggested a defect of cytoskeletal function, neutrophil chemotaxis in response to fMLP was also tested using a Dunn Migration Chamber The clinical and cellular phenotype of the patient suggested a novel disorder. Since the patient was born to a consanguineous family, we hypothesized that her disease was caused by a recessive Mendelian mutation and used whole exome sequencing to identify it. In the exome data we found 20,590 single nucleotide variants and small insertions/deletions, including 315 very rare ones, i.e. those not seen in the 6,500 NHLBI Exomes (8), 1000
Genomes database (April 2012 data release) (9) or 2,500 exomes analyzed internally using the same bioinformatics pipeline. Of these rare variants, three were homozygous (Table S2) 
MKL1 -deficiency impairs neutrophil migration
While MKL1 is known to be important for cytoskeletal regulation, to our knowledge its role in immune cell function has never been studied. To confirm that impaired neutrophil function resulted from disruption of MKL1 in our patient, we utilised shRNA lentiviral vectors to specifically silence MKL1 in the HL-60 myeloid cell line (Figure 3a 
MKL1 regulates cytoskeletal functions of dendritic cells.
To determine whether MKL1 is required for cytoskeletal regulation in other myeloid lineage immune cells, we generated dendritic cells (DCs) from patient CD14+ monocytes and analysed them for cytoskeletal morphology and adhesion. We found that patient MKL1- (Table 1,   Table S3 ). A notable feature of dHL-60 MKL1 cells was an abnormally elongated uropod, suggesting impaired retraction during migration. When uniformly stimulated with fMLP, 43% (+/-5%) of MKL1-silenced dHL-60 cells displayed this morphology, compared with 15% (+/-1.5%) of control cells (Figure 7a, b) . As uropod retraction is regulated by the myosin II protein complex 13 , we reasoned that MKL1-deficiency could impair neutrophil migration through effects on myosin II. As expected, disruption of myosin II interaction with F-actin using blebbistatin produced impaired uropod retraction similar 14 to that observed in dHL-60 MKL1 cells (Figure 7c ). Furthermore, expression of myosin regulatory light chain 
Discussion
MKL1 was first identified in association with acute megakaryoblastic leukaemia, where it is a component of a fusion protein generated by chromosomal translocation 15 . Subsequent investigation of MKL1 function in hematopoietic cells has focused on megakaryocytes and MKL1-deficiency in mice has been shown to result in cytoskeletal defects in this cell type disrupting differentiation, migration and proplatelet formation 9, 10, 16 . Our study is the first to describe human MKL1-deficiency and demonstrates that although mild thrombocytopenia is associated with the condition, the major phenotype appears to relate to immunodeficiency.
Through direct interaction with the transcription factor, SRF, MKL1 regulates the translation of cytoskeletal genes 17 in multiple cell types to control cellular processes including migration, adhesion and differentiation 9, [18] [19] [20] . In keeping with this, we demonstrate here that MKL1 plays a non-redundant role in maintaining normal levels of F-actin in both lymphoid and myeloid lineage cells. As the infection phenotype of our patient was prominent bacterial susceptibility, we initially studied the impact of MKL1-deficiency on neutrophils. In the absence of MKL1 activity, neutrophil actin cytoskeleton is severely perturbed evidenced by defects of phagocytosis and migration. Our data suggests that the mechanisms of cytoskeletal dysfunction in MKL1-deficient cells are multifactorial. A significant component is reduced expression of G-actin that we observed both at RNA and protein levels. However, forced reconstitution of G-actin using lentivectors did not fully restore intracellular F-actin levels suggesting that other MKL1-dependent cytoskeletal-regulators are critical for normal F-actin assembly. Using qPCR arrays, we found that multiple actin-associated genes were differentially expressed, supporting a complex role for MKL1 in cytoskeletal dynamics.
Somewhat surprisingly, only a minority of actin-associated genes were downregulated (3/18), although this group included cortactin (CTTN), CDC42BPA and FNBP1L all of which promote F-actin assembly through the CDC42/WASp/Arp2/3 pathway in haematopoietic cells [21] [22] [23] [24] . In keeping with the role of MKL1 as an SRF activator, our findings are reminiscent of the SRF-deficient mouse model in which neutrophils were shown to demonstrate reduced levels of F-actin associated with impaired polarisation, migration and recruitment to areas of inflammation 25 . In both MKL1 and SRF-deficiency, neutrophil numbers appear to be unaffected suggesting that, despite causing intrinsic cytoskeletal defects, these factors do not significantly impair development or release of neutrophils from the bone marrow.
For personal use only. on May 1, 2017. by guest www.bloodjournal.org From Neutrophils classically migrate in an amoeboid fashion, characterised by lamellipodial extension and subsequent uropod retraction, for which the family of small GTPases, nonmuscular myosin II and integrin trafficking are critical regulators [25] [26] [27] [28] . A prominent feature of MKL1-deficiency in neutrophil-like dHL-60 cells is abnormal uropod extension suggesting a defect of either myosin complex activity that supports uropod retraction or altered CD11b expression or activation at the cell surface. The uropod phenotype of MKL1-deficient neutrophils is mimicked by chemical inhibition of myosin complex function. It was previously shown, in CD34+ progenitor cells 9 , that loss of MKL1 results in significantly reduced expression of myosin light chain 9 (MYL9), a component of the myosin II complex.
Subsequent functional analysis demonstrated that MYL9 expression is a key cytoskeletal regulator both for platelet formation and megakaryocyte migration 9 . We observed reduced expression of myosin light chain in dHL-60 MKL1 which is in keeping with uropod dysfunction and suggests that MKL1-dependent MYL9 expression is involved in the cytoskeletal regulation during neutrophil migration. As seen in the SRF -/-mouse model, MKL1-deficient neutrophils over-expressed CD11b, which may be due to impaired integrin trafficking 25 . In SRF -/-mice, CD11b activation is impaired despite overexpression. Further investigation is required to determine the contribution of abnormal CD11b function to cytoskeletal dysfunction in MKL1-deficiency.
Given the role of MKL1 in megakaryocyte function, we were surprised that the observed thrombocytopenia in our patient was mild and did not lead to a clinically relevant bleeding disorder. This is unlikely to relate to residual expression of a small amount of truncated protein in our patient cells, as this did not appear preserve significant cytoskeletal function as evidenced by almost complete loss of neutrophil migration and DC podosome assembly.
The position of the truncation would be predicted to preserve the B1 basic box and glutamine-rich domains that mediate interaction with SRF 4 but disrupt the C-terminal transactivation domain (TAD) of MKL1 that confers transcriptional activity. This truncation has been modelled in vitro and demonstrated to retain nuclear localisation but completely abrogate MKL1 activity, which is in keeping with our findings 29 . It is possible that the mild effects on platelet production may relate to compensation by MKL2 as mkl1/mkl2 doubleknockout mice have a significantly more pronounced platelet deficiency 10 .
In addition to severe effects on neutrophils and mild effects on platelets, we show that MKL1
is important for cytoskeletal regulation in myeloid lineage DC and in lymphoid cells. The clinical phenotype observed may reflect the hierarchical importance of neutrophils for antibacterial defences, as seen in the CD18 integrin deficiency, Leukocyte Adhesion Defect, which presents as a neutrophil disorder although broader cellular effects exist, reflecting the importance for CD18 in many haematopoietic cell functions [30] [31] [32] . We also observed that MKL1-deficiency impaired fibroblast migration in vitro. This is consistent with the abnormal wound healing and scarring following superficial skin infections observed in our patient, and with previous reports of dysregulated fibroblast migration in vitro when MKL1/SRF function is manipulated genetically or chemically 33 . It is however surprising that other tissues do not appear to be grossly affected, as MKL1 is widely expressed and deficient mice exhibit partial embryonic lethality with myocardial cell necrosis. Other extra-haematopoietic manifestations of human MKL1-deficiency may therefore manifest with increasing age.
Taken together, these data demonstrate a non-redundant role for MKL1 in regulating the 
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